P rostate cancer (CaP) is the second most frequently diagnosed cancer of men worldwide (899 000 new cases, 13.6% of the total), with nearly 75% of the registered cases occurring in developed countries (644 000 cases). Blood prostate-specific antigen test has revolutionized the early detection of CaP and organ-confined CaP is effectively managed by state-of-the-art treatments including radical p...
